Composition
- Active ingredients
- CYCLOPHOSPHAMIDE 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CYCLOPHOSPHAMIDE 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA012142-002 · Discontinued
- CYCLOPHOSPHAMIDE 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- CYCLOPHOSPHAMIDE 25MG · TabletNDA012141-002 · Prescription
- CYCLOPHOSPHAMIDE 50MG · TabletNDA012141-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA012142.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cytoxan
- Active substance
- cyclophosphamide
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Baxter Hlthcare
- Status
- Discontinued
- FDA approval
- 16 Nov 1959
- Application
- NDA012142-001